Cybin Inc. Common Stock
HELP
Ранг среди акций
#11555
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
Цена акции
$10.30
Последняя синхронизация: 2026-08-11
Рыночная капитализация
$638.32M
Изменение (1 день)
2.88%
Изменение (1 год)
9,119.52%
Страна
CA
Торговля Cybin Inc. Common Stock (HELP)
Категория
Healthcare
История цены акций Cybin Inc. Common Stock (HELP)
Наивысшая цена закрытия: $0.12 2023-10-01
Наименьшая цена закрытия: $0.40 2021-06-01
Наименьшая цена закрытия: $0.40 2021-06-01
История цены акций Cybin Inc. Common Stock с 2021 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.70 | 7.84% |
CH
|
